Katy Hamana

Katy Hamana

Auto-generated profile, based on publicly available information

Katy Hamana

School of Healthcare Sciences, Cardiff University, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
LQLori Quinn
Lori Quinn
KHKaty Hamana
Katy Hamana
MKMark Kelson
Mark Kelson
HDHelen Dawes
Helen Dawes
JCJohnny Collett
Johnny Collett
MBMonica Busse
Monica Busse
This study aimed to evaluate the feasibility and benefit of a structured exercise intervention in people with Huntington's Disease (HD). This study was conducted at 6 sites, and participants were randomized into either exercise or control (usual care) groups, and were assessed at baseline, 13 and 26 weeks. The intervention was a 12 week, three times per week progressive exercise program, including aerobic (stationary cycling) and upper and lower body strengthening exercise with tapered 1:1 support for 20 of 36 sessions. 314 adults were assessed for eligibility: 248 did not meet inclusion criteria, 34 declined, and 32 were recruited and randomized. Three individuals in the intervention group were withdrawn within the first month due to concomitant medical conditions, resulting in 14 participants in intervention and 15 in control groups. There were two AEs in the intervention group, both related to previous medical conditions, and there were two SAEs, both in the control group. The intervention group had better fitness (predicted VO2 max difference: 492.3 ml min-1, 95% CI: [97.1, 887.6]), lower UHDRS mMS (difference 2.9 points, 95% [-5.42, -0.32]) and lower weight at Week 13 (difference 2.25 kg, 95% CI: [-4.47, -0.03]). This study demonstrates that a short-term exercise intervention is safe and feasible. Individuals with HD may benefit from structured exercise, and intensity, monitoring and support may be key factors in optimizing response. Larger scale trials are now required to fully elucidate the extended clinical potential of exercise in HD. Current Controlled Trials ISRCTN11392629.

1 September 2016 in Gait & Posture
Verified
Journal Article
Closed access
NFNora Fritz
Nora Fritz
KHKaty Hamana
Katy Hamana
MKMark Kelson
Mark Kelson
ARAnne Rosser
Anne Rosser
MBMonica Busse
Monica Busse
LQLori Quinn
Lori Quinn

28 June 2022 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
LQLori Quinn
Lori Quinn
RPRebecca Playle
Rebecca Playle
CDCheney J.G. Drew
Cheney J.G. Drew
KTKatie Taiyari
Katie Taiyari
RWRhys Williams-Thomas
Rhys Williams-Thomas
BLBernhard Landwehrmeyer
Bernhard Landwehrmeyer
While physical activity (PA) is recognized as important in Huntington's disease (HD) disease management, there has been no long-term evaluation undertaken. We aimed to evaluate the feasibility of a nested (within cohort) randomized controlled trial (RCT) of a physical therapist-led PA intervention. Participants were recruited from six HD specialist centers participating in the Enroll-HD cohort study in Germany, Spain and U.S. Assessments were completed at baseline and 12 months and linked to Enroll-HD cohort data. Participants at three sites (cohort) received no contact between baseline and 12 month assessments. Participants at three additional sites (RCT) were randomized to PA intervention or control group. The intervention consisted of 18 sessions delivered over 12 months; control group participants received no intervention, however both groups completed monthly exercise/falls diaries and 6-month assessments. 274 participants were screened, 204 met inclusion criteria and 116 were enrolled (59 in cohort; 57 in RCT). Retention rates at 12-months were 84.7% (cohort) and 79.0% (RCT). Data completeness at baseline ranged from 42.3 to 100% and at 12-months 19.2-85.2%. In the RCT, there was 80.5% adherence, high intervention fidelity, and similar adverse events between groups. There were differences in fitness, walking endurance and self-reported PA at 12 months favoring the intervention group, with data completeness >60%. Participants in the cohort had motor and functional decline at rates comparable to previous studies. Predefined progression criteria indicating feasibility were met. PACE-HD lays the groundwork for a future, fully-powered within cohort trial, but approaches to ensure data completeness must be considered. GOV: NCT03344601.

14 April 2018 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
JSJ.J. Steventon
J.J. Steventon
JCJ. Collett
J. Collett
HFH. Furby
H. Furby
KHK. Hamana
K. Hamana
CFC. Foster
C. Foster
HDHelen Dawes
Helen Dawes
Limited data suggests that an altered metabolic and cardiorespiratory exercise response may affect exercise performance in individuals with Huntington's disease (HD). There is no clear exploration of the response in individuals at different stages of the disease or in relation to genetic markers. This study aimed to examine the exercise response and recovery of HD participants, and the relationship to genetic and clinical markers. HD gene-positive participants (n = 31; 9 pre-manifest; 22 manifest HD) and a healthy control group (n = 29) performed an incremental exercise test until exhaustion. Performance, cardiorespiratory, metabolic and perceptual responses to exercise were determined from a maximal cycle ergometer test throughout the exercise test and during a recovery period. During sub-maximal exercise, metabolic (lactate levels, oxygen uptake) and cardiorespiratory markers (heart rate) were elevated in HD participants compared to controls. Lactate elevation was specific to pre-manifest HD participants. Work capacity was reduced in both pre-manifest and manifest HD participants with tests terminated with no difference in metabolic, perceptual or cardiorespiratory markers. Submaximal oxygen uptake was correlated with motor score, whilst peak measures were unrelated to genetic or clinical markers. Heart rate recovery was attenuated in pre-manifest and manifest HD participants. Our findings confirm metabolic and cardiorespiratory deficits reduce exercise performance and affect recovery from an early stage in HD, with submaximal deficits related to phenotypic expression. Exercise capacity appears to be limited by an altered movement economy, thus clinicians should consider an altered exercise response and recovery may affect prescription in HD.

17 May 2019 in Physical Therapy
Verified
Journal Article
Closed access
CDCheney J G Drew
Cheney J G Drew
LQLori Quinn
Lori Quinn
KHKaty Hamana
Katy Hamana
RWRhys Williams-Thomas
Rhys Williams-Thomas
LMLucy Marsh
Lucy Marsh
MBMonica Busse
Monica Busse
Background: Exercise is emerging as an important aspect in the management of disease-related symptoms and functional decline in people with Huntington disease (HD). Long-term evaluation of physical activity and exercise participation in HD has yet to be undertaken. Objective: The objective is to investigate the feasibility of a nested randomized controlled trial (RCT) alongside a longitudinal observational study of physical activity and exercise outcomes in people with HD. Design: This will be a 12-month longitudinal observational study (n = 120) with a nested evaluation of a physical activity intervention (n = 30) compared with usual activity (n = 30) using a “trial within a cohort” design. Setting: The study will take place in HD specialist clinics in Germany, Spain, and the United States, with intervention delivery in community settings. Participants: The participants will have early-mid–stage HD and be participating in the Enroll-HD study. Intervention: This will be a 12-month physical activity behavioral change intervention, delivered by physical therapists in 18 sessions, targeting uptake of aerobic exercise and increased physical activity. Measurements: All participants (n = 120) will complete Enroll-HD assessments (motor, cognitive, behavioral, and quality of life) at baseline and at 12 months. Additional Physical ACtivity and Exercise Outcomes in Huntington Disease (PACE-HD) assessments include fitness (predicted maximal oxygen uptake [V o2max]), self-reported and quantitative measures of physical activity, disease-specific symptoms, and walking endurance. RCT participants (n = 60) will complete an additional battery of quantitative motor assessments and a 6-month interim assessment. Enroll-HD data will be linked to PACE-HD physical activity and fitness data. Limitations: The limitations include that the embedded RCT is open, and assessors at RCT sites are not blinded to participant allocation. Conclusion: PACE-HD will enable determination of the feasibility of long-term physical activity interventions in people with HD. The novel “trial within a cohort” design and incorporation of data linkage have potential to reduce participant burden. This design could be applied to other neurological diseases and movement disorders where recruitment and retention are challenging.

22 May 2021 in Disability and Rehabilitation
Verified
Journal Article
Closed access
KHKaty Hamana
Katy Hamana
LQLori Quinn
Lori Quinn
TGTina Gambling
Tina Gambling
MBMonica Busse
Monica Busse
Purpose: Huntington?s disease is an autosomal dominant neurodegenerative disease. Progressive physical, behavioural and cognitive impairments cause loss of independent function. Physical activity interventions are important components of comprehensive intervention strategies and may help alter the functional decline trajectory. Qualitative research has an important role to play in developing theoretically sound, well-defined physical activity interventions in Huntington?s disease. Materials and methods: Eight focus groups were conducted with people with prodromal to late stage Huntington?s disease, caregivers (family members/formal), and healthcare professionals. An analytical coding framework was developed from the data and Levanthal?s self-regulation model to assist analysis. Results and conclusions: Key themes were identified: evolving representations of Huntington?s disease and physical activity; varying social environment of the person with Huntington?s disease and the impact on physical activity; achieving physical activity participation while coping with the nuances of Huntington?s disease. Levanthal?s model facilitated understanding of physical activity experiences, however with progression, self-regulation of activities needs to become more collaborative with caregivers. A modified self-regulation model specific to physical activity in Huntington?s disease is presented. Using a novel approach to generate new understanding of physical activity across the Huntington?s disease lifespan facilitated development of an original and significant theoretical foundation to underpin development of a range of much needed physical activity and exercise interventions in Huntington?s disease.